Radiopharm Theranostics (ASX:RAD) has announced an oral presentation at EANM 2023 from Investigator-Initiated Research2 conducted by the Fortis Memorial Research Institute.
Radiopharm Theranostics announces clinicaldData presentation for 68Ga-Trivehexin
September 18, 2023 Australian Biotech
Latest Video
New Stories
-
US FDA grants conditional approval to the brand name of Dimerix's DMX-200
September 25, 2023 - - Australian Biotech -
Budget outcome confirms double-digit growth for pharmaceutical spend
September 25, 2023 - - Latest News -
These major processes related to public health programs can not continue in this way
September 25, 2023 - - Latest News -
Hospital pharmacy launches new professional recognition program
September 25, 2023 - - Latest News -
The 'Week in Review' Podcast - 22 September
September 22, 2023 - - Podcast -
National and Labour commit to addressing Pharmac's fiscal 'cliff'
September 22, 2023 - - Latest News -
Moderna launches 'Welcome to the mRNAge' brand campaign
September 22, 2023 - - Latest News